When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XBIT - XBiotech in antibody manufacturing deal with J&J unit Janssen
XBiotech Inc.
XBiotech (XBIT -2.6%) will manufacture Johnson & Johnson (JNJ +0.2%) division Janssen Research & Development products, including the monoclonal antibody Xilonix (bermekimab). Xilonix was sold to Janssen by XBiotech in December 2019. That out-licensing deal, which allows Janssen to develop Xilonix for dermatology indication, was worth $1.35B to XBiotech.